Clinical Trial

  • Nuki, George (Principal Investigator)
  • Porteous, David (Co-investigator)

Project Details

StatusFinished
Effective start/end date1/11/0031/10/01

Funding

  • UK industry, commerce and public corporations: £28,023.00